News Nation on MSN
Blood protein could prevent deadly fungal infection: Study
A new study published in Nature found that albumin acted as a defense against mucormycosis.
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Albuked Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...
JUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company ...
Scientists have uncovered a surprising new hero in the fight against one of the world’s deadliest fungal infections: albumin, the most abundant protein in human blood. In a major international study, ...
EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Sonnet BioTherapeutics Holdings, Inc. announced that the ...
Albumin triggers fungal virulence: Candida albicans forms denser biofilms in the presence of human albumin (right) compared to its absence (left), revealing a hidden pathogenicity pathway. Candida ...
Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological activity. This study aimed to improve the method of active albumin ...
JUPITER, Fla. and ANKENY, Iowa - Dyadic Applied BioSolutions (NASDAQ:DYAI) and Proliant Health & Biologicals announced Tuesday the commercial launch of AlbuFree DX, a recombinant human albumin product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results